Yu Tung Hung

Ms. Yu Tung Hung


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
SCSung-Hsiung Chen
Sung-Hsiung Chen
Chen, Jui-FengChen, Jui-Feng
Chen, Jui-Feng
YHYu Tung Hung
Yu Tung Hung
THTzu-Ju Hsu
Tzu-Ju Hsu
Ching-Chih ChiuChing-Chih Chiu
Ching-Chih Chiu
Shu-Jui KuoShu-Jui Kuo
Shu-Jui Kuo
This study aimed to evaluate the systemic impact of periodontitis, previously considered a local disease, on cancer occurrence. We enrolled 683,854 participants, comparing cancer incidence among those with and without periodontitis and assessing the impact of periodontal treatment on cancer risk. Regardless of gender, age, Charlson comorbidity index, or the use of non-steroidal anti-inflammatory drugs, periodontitis patients had a lower overall cancer risk than controls. However, men with periodontitis had a higher risk of prostate cancer (adjusted hazard ratio [aHR] = 1.22; 95% confidence interval [CI] = 1.10–1.35), and both men and women had a higher risk of thyroid cancer (women: aHR = 1.20, 95%CI = 1.04–1.38; men: aHR = 1.51, 95% CI = 1.15–1.99). Patients with periodontitis who received treatment showed a reduced cancer risk (aHR = 0.41; 95% CI = 0.38–0.44) compared to untreated patients. Proper treatment for periodontitis may lower an individual’s cancer risk more than if they did not have the disease at all, suggesting that periodontitis is a modifiable risk factor for cancer.

28 October 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
YFYen Fu-Shun
Yen Fu-Shun
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI
YHYu Tung Hung
Yu Tung Hung
CHChih-Cheng Hsu
Chih-Cheng Hsu
CHChii-Min Hwu
Chii-Min Hwu

6 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
CWChao-Hsuan Wei
Chao-Hsuan Wei
CLChia-Hsiang Li
Chia-Hsiang Li
TSTe-Chun Shen
Te-Chun Shen
YHYu Tung Hung
Yu Tung Hung
CTChih-Yen Tu
Chih-Yen Tu
CHChung Y. Hsu
Chung Y. Hsu
Background: Pneumoconiosis has considerable comorbidities, most notably pulmonary and cardiovascular diseases. However, the relationship between pneumoconiosis and chronic kidney disease (CKD) is largely unknown. The present study aimed to use a retrospective cohort study design to further clarify the association between pneumoconiosis and subsequent CKD risk. Methods: This is a nationwide, population-based, retrospective cohort study that used data from Taiwan’s National Health Insurance Database. Between 2008 and 2018, 17,952 newly diagnosed patients were included in the pneumoconiosis cohort, while 71,808 individuals without pneumoconiosis were included in the comparison cohort, with a propensity score matching for age, gender, and date of pneumoconiosis diagnosis. The development of CKD was monitored until the end of 2019. The risk was assessed using Cox proportional hazard regression models. Results: After controlling for age, gender, and comorbidity, the overall incidence of CKD was 1.69-fold higher in the pneumoconiosis cohort than in the comparison cohort (19.71 vs. 11.76 per 1000 person-years, respectively, p < 0.001), with an adjusted hazard ratio of 1.83 (95% confidence interval: 1.73–1.93). Stratified analyses by age group, gender, and presence of comorbidity revealed that the adjusted hazard ratios of CKD associated with pneumoconiosis remained significant (8/9). Furthermore, pneumoconiosis and tri-high (hypertension, hyperglycemia, and hyperlipidemia) interact positively with CKD development (p < 0.001). Conclusion: Patients with pneumoconiosis had a significantly higher risk of developing CKD than those without. Pneumoconiosis combined with hypertension, hyperglycemia, or hyperlipidemia would increase the risk even further. More studies are required to understand the possible pathophysiological mechanisms.

3 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CHChi Chia Hsieh
Chi Chia Hsieh
YFYi Hsiu Fu
Yi Hsiu Fu
Nien-En KuNien-En Ku
Nien-En Ku
CHChia Chun Hsia
Chia Chun Hsia
YHYu Tung Hung
Yu Tung Hung
Shu-Jui KuoShu-Jui Kuo
Shu-Jui Kuo
Chronic pancreatitis (CP) may induce systemic inflammation, potentially increasing cancer susceptibility. However, the link between CP and extra-pancreatic cancer remains underexplored. Employing Taiwanese National Health Insurance Database data from 2000 to 2017, we compared 5394 CP patients with 21,576 non-CP individuals through propensity score matching. CP patients exhibited a significantly higher cancer risk (adjusted hazard ratio (aHR) of 1.32 for females and 1.68 for males) and cumulative incidence (p < 0.001) compared to non-CP individuals. CP showed notable associations with pancreatic (aHR = 3.51), liver (aHR = 1.62), stomach (aHR = 2.01), and other cancers (aHR = 2.09). In terms of liver cancer, CP was significantly associated with patients without viral hepatitis, regardless of gender (aHR = 2.01 for women; aHR = 1.54 for men). No significant cancer occurrences were observed within the first year following CP diagnosis. Pancreatic or liver cancer developed in approximately half of CP patients within 2–3 years, while gastric cancer in male CP patients predominantly occurred around the fifth year after diagnosis. These findings inform potential cancer-screening plans for CP patients.

YFYen Fu-Shun
Yen Fu-Shun
CHChih-Cheng Hsu
Chih-Cheng Hsu
KHKai-Chieh Hu
Kai-Chieh Hu
YHYu Tung Hung
Yu Tung Hung
CHChung Y. Hsu
Chung Y. Hsu
CHChii-Min Hwu
Chii-Min Hwu
We conducted this study to determine the effect of metformin use on the risk of new-onset chronic urticaria in patients with type 2 diabetes (T2D). In total, 24,987 pairs of metformin users and nonusers were identified with propensity score-matching from Taiwan’s National Health Insurance Research Database from 1 January 2000, to 31 December 2017. Multivariable Cox proportional hazards models were used to compare the risks of chronic urticaria development, severe chronic urticaria, and hospitalization for chronic urticaria between metformin users and nonusers. Compared with metformin nonuse, the aHRs (95% CI) for metformin use in chronic urticaria development, severe chronic urticaria, and hospitalization for chronic urticaria were 1.56 (1.39–1.74), 0.40 (0.12–1.30), and 1.45 (0.82–2.56), respectively. The cumulative incidence of chronic urticaria development was significantly higher in metformin users than in nonusers (p < 0.0001). A longer average cumulative duration of metformin use was associated with higher risks of new-onset and hospitalization for chronic urticaria than metformin nonuse. This nationwide cohort study showed that metformin use was associated with a significantly higher risk of chronic urticaria development. A longer average cumulative duration of metformin use was associated with a higher risk of outcomes. More prospective studies are needed to verify our results.

2 July 2024 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
CHCheng-Hao Huang
Cheng-Hao Huang
SLShun-Ku Lin
Shun-Ku Lin
HLHeng-Jun Lin
Heng-Jun Lin
YHYu Tung Hung
Yu Tung Hung
THTzu-Ju Hsu
Tzu-Ju Hsu
CHChing-Liang Hsieh
Ching-Liang Hsieh
Recent research has established an association between insomnia and an elevated risk of stroke. Given the severe global impact of stroke on public health, exploring nonpharmacological interventions, such as acupuncture, that can mitigate stroke risk among individuals with insomnia is crucial. In this retrospective cohort study, we used data from the Taiwan National Health Insurance Database (NHIRD) to examine the relationship between acupuncture and the risk of stroke among individuals who received a diagnosis of insomnia between 2000 and 2017. The study participants were divided into two cohorts: the acupuncture group that received acupuncture and a matched control group that did not. The primary outcome was the occurrence of stroke. Of the 217,356 patients included in the study, 3668 individuals in the acupuncture group and 4913 in the control group experienced stroke. The incidence rate of stroke was lower in the acupuncture group (4.51 per 1000 person-years) than in the control group (6.86 per 1000 person-years). After adjustment for various potential confounders, patients who received acupuncture exhibited a notably reduced risk of stroke, with an adjusted hazard ratio of 0.66 (95 % confidence interval [CI]: 0.63, 0.69). Furthermore, a dose–response relationship was evident, in that individuals who received 6–11 acupuncture sessions experienced a 24 % reduction in stroke risk, whereas those who received 12–17 sessions, 18–29 sessions, and ≥30 sessions exhibited reductions of 31 %, 34 %, and 42 %, respectively. Acupuncture treatment was significantly associated with a reduced risk of stroke among patients with insomnia.